A 37-year-old female with a history of hypertension for 5 years was brought to the emergency room with swelling of the tongue and neck after the second dose of enalapril. After administration of hydrocortisone by her physician, she went to the emergency room. Her dyspnea and dysarthria were relieved. However, she experienced recurrence of the symptomsfollowed by respiratory arrest. She suffered severe anoxic brain damage and died three days later. Although angioedema is a rare occurrence with the use of enalapril, it is potentially life threatening. (Internal Medicine 32: 308-310, 1993) 
Introduction
Angiotensin-converting enzyme (ACE) inhibitors have been widely used as effective anti-hypertensive agents, and more recently used for the treatment of congestive heart failure (1). Although generally well tolerated, numerous side effects have been reported (2-4). Headache, dizziness, fatigue, diarrhea, skin rash, cough and nausea are the more common(1 to 5%) side effects. Her dyspnea had been relieved when she was presented to the emergencyroom. Her consciousness was clear. Her tongue was markedly swollen and protruded, so she could not close her mouth (Fig. 1 ). Her anterior neck was also markedly swollen ( Fig. 2) . No other areas of the body were affected by this reaction. On physical examination, her blood pressure was 198/100mmHg, pulse 100/min, respiration 28/min, and body temperature 37.4°C. Electrocardiogram and chest roentgenogram showed no remarkable changes. Laboratory tests were unremarkable except leukocytosis (8,900/mm3). Computed tomographic scan showed swelling of the soft tissues from the upper pharynx to sub-vocal cords, tongue and vocal cords (Fig. 3) . It also showed swelling of the mucosaof the trachea and the soft tissue around it, and narrowing of the trachea in other slices. Weconsidered the condition of the patient to be relatively stable, therefore no additional doses of hydrocortisone nor chlorophenilamine maleate were administered.
Approximately two hours after admission, the patient's condition rapidly deteriorated with severe respiratory distress and stridor. Intravenous adrenaline was immediately administered. Despite this treatment, respiratory arrest followed. Oral endotracheal intubation was attempted but was unsuccessful due to severe laryngeal edema. Subsequently a needle cricothyroidotomy was performed, and was followed by a tracheotomy. The Angioedema Associated with Enalapril total anoxic period was 8 minutes, and hemodynamic deterioration ensued with development of ventricular fibrillation. Eventually, her hemodynamics were stabilized by positive inotropic agents, but severe anoxic brain damage persisted. On the third day of hospitalization, brain death was diagnosed and declared. A request for a post mortemexamination was refused.
Discussion
The term angioedema denotes a well-demarcated, non-pitting edema that occurs as large erythematous areas in the skin, mucosa and subcutaneous tissues (3).
It most commonly involves the face, lips and glossopharyngeal areas. In some instances it maycause respiratory distress, caused primarily by laryngeal edema.
Hereditary and acquired types have been described (3). Hereditary angioedema is rare, with acquired or idiopathic angioedema being more common.It is associated with many precipitating factors, such as foods, insect stings, infections, transfusions and a variety of drugs. The mechanism of angioedema associated with ACE inhibitors remains unclarified, but it is assumed that a biochemical phenomenon, not an immunologic mechanism, mediated through the kallikrein-kinin system plays a role (5). ACEinhibitors are known to decrease the metabolism of bradykinin; increased levels of tissue bradykinin, which is a potent vasodilator that also increases vascular permeability, are thought to be the cause of angioedema. The incidence of angioedema associated with the use of ACE inhibitors has been estimated to be from 0.1 to 0.2% (2-4). Angioedema occurs at the initiation of the drug therapy. Although the majority of cases were reported to occur within the first week of therapy, especially within the first few doses (6), Hedner et al reported cases in which angioedema occurred after over three months and three years on ACEinhibitors (7).
In the present case, severe symptoms recurred after 
